The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 million sales milestone payment from its ...

The achievement of the first sales milestone already in the second year of commercialization is a testament of the commercial capability of our partner AKP in this important market. The strong sales ...

CES event showcased cutting-edge health tech innovations, including smart diapers, AI-powered glasses, and a walking ...

Japanese technology company Asahi Kasei and Italian manufacturer Aquafil are developing a novel materialfor 3D printing.

Asahi Kasei Co. (OTCMKTS:AHKSY – Get Free Report) was the recipient of a large increase in short interest in the month of ...

This milestone follows the successful closure of a $35M strategic investment round with participation from new investors including Mitsubishi Corporation, Asahi Kasei Corporation, InBC Investment Corp ...

A Aa Aaaaaaaaaaaa 43.85 +23.89% ...

Offering reduced changeover time while maintaining safety and product quality TOKYO & NEW YORK & DÃœSSELDORF, Germany--(BUSINESS WIRE)--Generating cutting-edge therapeutics ...

Explore the detailed Asahi Kaisei Corp balance sheet to understand the company’s financial health and stability. This page provides a clear breakdown of key metrics, including total assets ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...